C2C Wealth Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-45,160
Closed -$612K 203
2023
Q3
$612K Buy
45,160
+13,005
+40% +$166K 0.09% 118
2023
Q2
$405K Buy
32,155
+555
+2% +$6.32K 0.05% 175
2023
Q1
$371K Buy
+31,600
New +$391K 0.06% 176

Other funds holding SBRA

C2C Wealth Management's SBRA Position: Q4 2023 in Review

C2C Wealth Management sold out of Sabra Healthcare REIT (SBRA) in Q4 2023, closing a stake of 45,160 shares — an estimated $612K sold.

C2C Wealth Management first reported a position in SBRA in Q1 2023 and held it in 3 quarters. The position peaked at $612K in Q3 2023. 359 funds tracked by Wall St. Rank hold SBRA as of Q4 2023.

  • C2C Wealth Management reported no remaining Sabra Healthcare REIT position as of Q4 2023 after selling out during the quarter.
  • C2C Wealth Management sold 45,160 Sabra Healthcare REIT shares in Q4 2023, an estimated $612K.
  • C2C Wealth Management first reported a position in Sabra Healthcare REIT in Q1 2023 and held it in 3 quarters.
  • C2C Wealth Management's Sabra Healthcare REIT position peaked at $612K in Q3 2023.
  • 359 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2023.

Based on C2C Wealth Management's 13F filing for Q4 2023, filed 13 Feb 2024.